An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza

Commun Biol. 2023 Jun 3;6(1):600. doi: 10.1038/s42003-023-04982-0.

Abstract

Excessive inflammation is a postulated cause of severe disease and death in respiratory virus infections. In response to severe influenza virus infection, adoptively transferred naïve hemagglutinin-specific CD4+ T cells from CD4+ TCR-transgenic 6.5 mice drive an IFN-γ-producing Th1 response in wild-type mice. It helps in virus clearance but also causes collateral damage and disease aggravation. The donor 6.5 mice have all the CD4+ T cells with TCR specificity toward influenza hemagglutinin. Still, the infected 6.5 mice do not suffer from robust inflammation and grave outcome. The initial Th1 response wanes with time, and a prominent Th17 response of recent thymic emigrants alleviates inflammation and bestows protection in 6.5 mice. Our results suggest that viral neuraminidase-activated TGF-β of the Th1 cells guides the Th17 evolution, and IL-17 signaling through the non-canonical IL-17 receptor EGFR activates the scaffold protein TRAF4 more than TRAF6 during alleviation of lung inflammation in severe influenza.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • ErbB Receptors
  • Hemagglutinins
  • Humans
  • Inflammation
  • Influenza, Human*
  • Interferon-gamma
  • Interleukin-17
  • Mice
  • Mice, Transgenic
  • Pneumonia*
  • Receptors, Antigen, T-Cell
  • TNF Receptor-Associated Factor 4

Substances

  • Hemagglutinins
  • Interleukin-17
  • TNF Receptor-Associated Factor 4
  • Interferon-gamma
  • Receptors, Antigen, T-Cell
  • ErbB Receptors